Observational studyDrug design, development and therapy2026
Real-World Efficacy and Safety of Adalimumab Biosimilar (HS016) in Biologic-Naïve Patients with Perianal Fistulizing Crohn's Disease: A Prospective, Single-Arm, Observational Study.
Qi Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.